Type |
Details |
Score |
Publication |
First Author: |
Mueller A |
Year: |
2008 |
Journal: |
J Leukoc Biol |
Title: |
CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. |
Volume: |
83 |
Issue: |
4 |
Pages: |
875-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qin H |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. |
Volume: |
181 |
Issue: |
5 |
Pages: |
3167-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ding W |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. |
Volume: |
181 |
Issue: |
9 |
Pages: |
6020-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Clutter SD |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. |
Volume: |
182 |
Issue: |
1 |
Pages: |
234-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hultcrantz M |
Year: |
2009 |
Journal: |
Diabetologia |
Title: |
The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice. |
Volume: |
52 |
Issue: |
2 |
Pages: |
299-305 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dvoriantchikova G |
Year: |
2009 |
Journal: |
Eur J Neurosci |
Title: |
Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. |
Volume: |
30 |
Issue: |
2 |
Pages: |
175-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Struyf S |
Year: |
2011 |
Journal: |
Blood |
Title: |
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. |
Volume: |
117 |
Issue: |
2 |
Pages: |
480-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Camelo S |
Year: |
2015 |
Journal: |
Mol Vis |
Title: |
Thinning of the RPE and choroid associated with T lymphocyte recruitment in aged and light-challenged mice. |
Volume: |
21 |
|
Pages: |
1051-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yan C |
Year: |
2016 |
Journal: |
Am J Pathol |
Title: |
Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas. |
Volume: |
186 |
Issue: |
6 |
Pages: |
1466-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Westman J |
Year: |
2015 |
Journal: |
PLoS Pathog |
Title: |
Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. |
Volume: |
11 |
Issue: |
12 |
Pages: |
e1005319 |
|
•
•
•
•
•
|
Publication |
First Author: |
Trucco LD |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma. |
Volume: |
12 |
Issue: |
6 |
Pages: |
e0179897 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ivin M |
Year: |
2017 |
Journal: |
PLoS Pathog |
Title: |
Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection. |
Volume: |
13 |
Issue: |
11 |
Pages: |
e1006696 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manning BM |
Year: |
2015 |
Journal: |
Biochim Biophys Acta |
Title: |
Single-cell analysis of mast cell degranulation induced by airway smooth muscle-secreted chemokines. |
Volume: |
1850 |
Issue: |
9 |
Pages: |
1862-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Losada-Barragán M |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Protein malnutrition promotes dysregulation of molecules involved in T cell migration in the thymus of mice infected with Leishmania infantum. |
Volume: |
7 |
|
Pages: |
45991 |
|
•
•
•
•
•
|
Publication |
First Author: |
Garg AD |
Year: |
2017 |
Journal: |
Cell Death Differ |
Title: |
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing. |
Volume: |
24 |
Issue: |
5 |
Pages: |
832-843 |
|
•
•
•
•
•
|
Publication |
First Author: |
Recasens M |
Year: |
2019 |
Journal: |
Glia |
Title: |
Astrocyte-targeted IL-10 production decreases proliferation and induces a downregulation of activated microglia/macrophages after PPT. |
Volume: |
67 |
Issue: |
4 |
Pages: |
741-758 |
|
•
•
•
•
•
|
Publication |
First Author: |
Britto CJ |
Year: |
2019 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation. |
Volume: |
316 |
Issue: |
2 |
Pages: |
L321-L333 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tatsumi K |
Year: |
2019 |
Journal: |
Cell Immunol |
Title: |
Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection. |
Volume: |
344 |
|
Pages: |
103949 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shono K |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma. |
Volume: |
10 |
Issue: |
1 |
Pages: |
15286 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yan Y |
Year: |
2021 |
Journal: |
Cancer Lett |
Title: |
Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC). |
Volume: |
506 |
|
Pages: |
95-106 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaesler S |
Year: |
2019 |
Journal: |
JCI Insight |
Title: |
Targeting tumor-resident mast cells for effective anti-melanoma immune responses. |
Volume: |
4 |
Issue: |
19 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Chandrasekar B |
Year: |
2013 |
Journal: |
J Infect Dis |
Title: |
Regulation of chemokines, CCL3 and CCL4, by interferon γ and nitric oxide synthase 2 in mouse macrophages and during Salmonella enterica serovar typhimurium infection. |
Volume: |
207 |
Issue: |
10 |
Pages: |
1556-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akeus P |
Year: |
2021 |
Journal: |
Eur J Immunol |
Title: |
Regulatory T cells reduce endothelial neutral sphingomyelinase 2 to prevent T-cell migration into tumors. |
Volume: |
51 |
Issue: |
9 |
Pages: |
2317-2329 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fernández-Laso V |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice. |
Volume: |
7 |
|
Pages: |
46679 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohkuri T |
Year: |
2014 |
Journal: |
Cancer Immunol Res |
Title: |
STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. |
Volume: |
2 |
Issue: |
12 |
Pages: |
1199-208 |
|
•
•
•
•
•
|
Publication |
First Author: |
Antonia RJ |
Year: |
2022 |
Journal: |
J Cell Mol Med |
Title: |
STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. |
Volume: |
26 |
Issue: |
16 |
Pages: |
4591-4601 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schröder LJ |
Year: |
2023 |
Journal: |
Glia |
Title: |
Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination. |
Volume: |
71 |
Issue: |
11 |
Pages: |
2573-2590 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dery KJ |
Year: |
2023 |
Journal: |
Sci Transl Med |
Title: |
Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans. |
Volume: |
15 |
Issue: |
707 |
Pages: |
eadf2059 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cao Y |
Year: |
2024 |
Journal: |
Carcinogenesis |
Title: |
ETS1 deficiency in macrophages suppresses colorectal cancer progression by reducing the F4/80+TIM4+ macrophage population. |
Volume: |
45 |
Issue: |
10 |
Pages: |
745-758 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lian J |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
Targeting Lymph Node Niches Enhances Type 1 Immune Responses to Immunization. |
Volume: |
31 |
Issue: |
8 |
Pages: |
107679 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo Y |
Year: |
2020 |
Journal: |
Cell Host Microbe |
Title: |
During Aspergillus Infection, Monocyte-Derived DCs, Neutrophils, and Plasmacytoid DCs Enhance Innate Immune Defense through CXCR3-Dependent Crosstalk. |
Volume: |
28 |
Issue: |
1 |
Pages: |
104-116.e4 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Cole KE |
Year: |
1998 |
Journal: |
J Exp Med |
Title: |
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. |
Volume: |
187 |
Issue: |
12 |
Pages: |
2009-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weng Y |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. |
Volume: |
273 |
Issue: |
29 |
Pages: |
18288-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Loetscher M |
Year: |
1996 |
Journal: |
J Exp Med |
Title: |
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. |
Volume: |
184 |
Issue: |
3 |
Pages: |
963-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
GarcÃa-López MA |
Year: |
2001 |
Journal: |
Lab Invest |
Title: |
CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. |
Volume: |
81 |
Issue: |
3 |
Pages: |
409-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Booth V |
Year: |
2002 |
Journal: |
Biochemistry |
Title: |
The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. |
Volume: |
41 |
Issue: |
33 |
Pages: |
10418-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tensen CP |
Year: |
1999 |
Journal: |
J Invest Dermatol |
Title: |
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). |
Volume: |
112 |
Issue: |
5 |
Pages: |
716-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Smit MJ |
Year: |
2003 |
Journal: |
Blood |
Title: |
CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. |
Volume: |
102 |
Issue: |
6 |
Pages: |
1959-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hancock WW |
Year: |
2000 |
Journal: |
J Exp Med |
Title: |
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. |
Volume: |
192 |
Issue: |
10 |
Pages: |
1515-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mach F |
Year: |
1999 |
Journal: |
J Clin Invest |
Title: |
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. |
Volume: |
104 |
Issue: |
8 |
Pages: |
1041-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Panzer U |
Year: |
2007 |
Journal: |
J Am Soc Nephrol |
Title: |
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. |
Volume: |
18 |
Issue: |
7 |
Pages: |
2071-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qin S |
Year: |
1998 |
Journal: |
J Clin Invest |
Title: |
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. |
Volume: |
101 |
Issue: |
4 |
Pages: |
746-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Curbishley SM |
Year: |
2005 |
Journal: |
Am J Pathol |
Title: |
CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. |
Volume: |
167 |
Issue: |
3 |
Pages: |
887-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Loetscher P |
Year: |
2000 |
Journal: |
Adv Immunol |
Title: |
Chemokines and their receptors in lymphocyte traffic and HIV infection. |
Volume: |
74 |
|
Pages: |
127-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zlotnik A |
Year: |
1999 |
Journal: |
Crit Rev Immunol |
Title: |
Recent advances in chemokines and chemokine receptors. |
Volume: |
19 |
Issue: |
1 |
Pages: |
1-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yates CC |
Year: |
2007 |
Journal: |
Am J Pathol |
Title: |
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. |
Volume: |
171 |
Issue: |
2 |
Pages: |
484-95 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.This entry represents CXCR3, which is expressed in natural killer cells and activated T lymphocytes but not in resting T lymphocytes, B lymphocytes, monocytes or granulocytes [, ]. CXCR3 also appears to be constitutively expressed on endothelial cells of medium and large blood vessels []. CXCR3 is able to regulate leukocyte trafficking and binding to various chemokines inducing various cellular responses, most notably integrin activation, cytoskeletal changes and chemotactic migration [, , , ]. The main role of CXCR3 is the selective recruitment of effector T cells in both normal tissues and inflammation []and it is involved in a number of T cell-mediated inflammatory diseases, such as autoimmune diseases, delayed-type hypersensitivity responses, certain viral diseases and acute transplant rejection []. It has been implicated in atherosclerosis [], pulmonary fibrosis [], type 1 diabetes []and nephrotoxic nephritis [], and has been implicated in wound healing [].CXCR3 is the receptor for CXCL9 (Mig), CXCL10 (IP10) and CXCL11 (I-TAC), [, , , ], which are upregulated in response to interferon-gamma and are potent chemoattractants for activated T cells [, ]. All three chemokines elicit an increase in intracellular Ca2+ levels and activate phosphoinositide 3-kinase and mitogen-activated protein kinase (MAPK) []. CXCR3 is also capable of binding a number of CC chemokines with moderate affinity, including CCL11 (eotaxin), CCL13, CCL20, CCL7, CCL5 []. However, it has been reported that CCL11, despite binding with high affinity, may be neither an agonist or an antagonist of the CXCR3 receptor, but sequesters available CCL11 resulting in a lowered response at other receptors []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamamoto H |
Year: |
2014 |
Journal: |
Infect Immun |
Title: |
Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans. |
Volume: |
82 |
Issue: |
4 |
Pages: |
1606-15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhong Y |
Year: |
2019 |
Journal: |
Mol Immunol |
Title: |
The novel methyltransferase SETD4 regulates TLR agonist-induced expression of cytokines through methylation of lysine 4 at histone 3 in macrophages. |
Volume: |
114 |
|
Pages: |
179-188 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu L |
Year: |
2021 |
Journal: |
Front Immunol |
Title: |
Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice. |
Volume: |
12 |
|
Pages: |
584414 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zacharias ZR |
Year: |
2019 |
Journal: |
J Immunol |
Title: |
Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections. |
Volume: |
203 |
Issue: |
12 |
Pages: |
3313-3324 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bucher F |
Year: |
2020 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10. |
Volume: |
61 |
Issue: |
10 |
Pages: |
20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu CL |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. |
Volume: |
6 |
Issue: |
1 |
Pages: |
e16171 |
|
•
•
•
•
•
|
Publication |
First Author: |
Viau A |
Year: |
2020 |
Journal: |
J Am Soc Nephrol |
Title: |
Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease. |
Volume: |
31 |
Issue: |
5 |
Pages: |
1035-1049 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mastronardi CA |
Year: |
2015 |
Journal: |
Neuroimmunomodulation |
Title: |
Temporal gene expression in the hippocampus and peripheral organs to endotoxin-induced systemic inflammatory response in caspase-1-deficient mice. |
Volume: |
22 |
Issue: |
4 |
Pages: |
263-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ellis SL |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. |
Volume: |
185 |
Issue: |
3 |
Pages: |
1864-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
RodrÃguez M |
Year: |
2017 |
Journal: |
Immunology |
Title: |
Fungal pattern receptors down-regulate the inflammatory response by a cross-inhibitory mechanism independent of interleukin-10 production. |
Volume: |
150 |
Issue: |
2 |
Pages: |
184-198 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fabris L |
Year: |
2022 |
Journal: |
FASEB J |
Title: |
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis. |
Volume: |
36 |
Issue: |
6 |
Pages: |
e22364 |
|
•
•
•
•
•
|
Publication |
First Author: |
Snyder JD |
Year: |
2024 |
Journal: |
Front Immunol |
Title: |
Protein kinase D1 in myeloid lineage cells contributes to the accumulation of CXCR3(+)CCR6(+) nonconventional Th1 cells in the lungs and potentiates hypersensitivity pneumonitis caused by S. rectivirgula. |
Volume: |
15 |
|
Pages: |
1403155 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coburn LA |
Year: |
2019 |
Journal: |
Oncogene |
Title: |
Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. |
Volume: |
38 |
Issue: |
7 |
Pages: |
1067-1079 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma P |
Year: |
2024 |
Journal: |
Circulation |
Title: |
Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. |
Volume: |
149 |
Issue: |
1 |
Pages: |
48-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu Z |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein. |
Volume: |
11 |
Issue: |
10 |
Pages: |
e0162905 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liao YC |
Year: |
2021 |
Journal: |
Front Immunol |
Title: |
NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities. |
Volume: |
12 |
|
Pages: |
743030 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bleau C |
Year: |
2016 |
Journal: |
Immunology |
Title: |
Toll-like receptor-2 exacerbates murine acute viral hepatitis. |
Volume: |
149 |
Issue: |
2 |
Pages: |
204-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rudobeck E |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel. |
Volume: |
12 |
Issue: |
11 |
Pages: |
e0186168 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee HJ |
Year: |
2024 |
Journal: |
Front Immunol |
Title: |
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD. |
Volume: |
15 |
|
Pages: |
1421455 |
|
•
•
•
•
•
|
Publication |
First Author: |
He Y |
Year: |
2019 |
Journal: |
Hepatology |
Title: |
MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Sohail A |
Year: |
2022 |
Journal: |
PLoS Pathog |
Title: |
Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. |
Volume: |
18 |
Issue: |
1 |
Pages: |
e1010219 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tan BM |
Year: |
2013 |
Journal: |
Diabetologia |
Title: |
Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells. |
Volume: |
56 |
Issue: |
3 |
Pages: |
520-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su Z |
Year: |
2023 |
Journal: |
J Dermatol |
Title: |
Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis. |
Volume: |
50 |
Issue: |
10 |
Pages: |
1321-1329 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stubblefield Park SR |
Year: |
2011 |
Journal: |
J Virol |
Title: |
T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue. |
Volume: |
85 |
Issue: |
7 |
Pages: |
3664-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaur S |
Year: |
2007 |
Journal: |
J Biol Chem |
Title: |
Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. |
Volume: |
282 |
Issue: |
3 |
Pages: |
1757-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fujita M |
Year: |
2011 |
Journal: |
Cancer Res |
Title: |
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. |
Volume: |
71 |
Issue: |
7 |
Pages: |
2664-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen SH |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors. |
Volume: |
7 |
Issue: |
5 |
Pages: |
e36984 |
|
•
•
•
•
•
|
Publication |
First Author: |
Listwak SJ |
Year: |
2013 |
Journal: |
Neuroscience |
Title: |
Minimal NF-κB activity in neurons. |
Volume: |
250 |
|
Pages: |
282-299 |
|
•
•
•
•
•
|
Publication |
First Author: |
Teunissen PF |
Year: |
2015 |
Journal: |
Cardiovasc Res |
Title: |
MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden. |
Volume: |
107 |
Issue: |
2 |
Pages: |
255-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsiantoulas D |
Year: |
2018 |
Journal: |
Circulation |
Title: |
B Cell-Activating Factor Neutralization Aggravates Atherosclerosis. |
Volume: |
138 |
Issue: |
20 |
Pages: |
2263-2273 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma P |
Year: |
2023 |
Journal: |
bioRxiv |
Title: |
Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Gola A |
Year: |
2021 |
Journal: |
Nature |
Title: |
Commensal-driven immune zonation of the liver promotes host defence. |
Volume: |
589 |
Issue: |
7840 |
Pages: |
131-136 |
|
•
•
•
•
•
|
Publication |
First Author: |
Syeda S |
Year: |
2015 |
Journal: |
Exp Neurol |
Title: |
Reduced photoreceptor death and improved retinal function during retinal degeneration in mice lacking innate immunity adaptor protein MyD88. |
Volume: |
267 |
|
Pages: |
1-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Church KA |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249/M280)-expressing retina. |
Volume: |
14 |
|
Pages: |
1130735 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krauthausen M |
Year: |
2014 |
Journal: |
J Neuroinflammation |
Title: |
CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system. |
Volume: |
11 |
|
Pages: |
109 |
|
•
•
•
•
•
|
Publication |
First Author: |
Berretta F |
Year: |
2019 |
Journal: |
Front Immunol |
Title: |
Plasmodium chabaudi AS Infection Induces CD4+ Th1 Cells and Foxp3+T-bet+ Regulatory T Cells That Express CXCR3 and Migrate to CXCR3 Ligands. |
Volume: |
10 |
|
Pages: |
425 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang BC |
Year: |
2017 |
Journal: |
J Neurosci |
Title: |
Promoted Interaction of C/EBPα with Demethylated Cxcr3 Gene Promoter Contributes to Neuropathic Pain in Mice. |
Volume: |
37 |
Issue: |
3 |
Pages: |
685-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo X |
Year: |
2021 |
Journal: |
J Neuroinflammation |
Title: |
Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain. |
Volume: |
18 |
Issue: |
1 |
Pages: |
169 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jodeleit H |
Year: |
2020 |
Journal: |
PLoS One |
Title: |
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis. |
Volume: |
15 |
Issue: |
2 |
Pages: |
e0228615 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du X |
Year: |
2021 |
Journal: |
Mol Neurodegener |
Title: |
Deletion of Socs3 in LysM+ cells and Cx3cr1 resulted in age-dependent development of retinal microgliopathy. |
Volume: |
16 |
Issue: |
1 |
Pages: |
9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Murphy PM |
Year: |
2000 |
Journal: |
Pharmacol Rev |
Title: |
International union of pharmacology. XXII. Nomenclature for chemokine receptors. |
Volume: |
52 |
Issue: |
1 |
Pages: |
145-76 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
367
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma Q |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. |
Volume: |
95 |
Issue: |
16 |
Pages: |
9448-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Horuk R |
Year: |
2001 |
Journal: |
Cytokine Growth Factor Rev |
Title: |
Chemokine receptors. |
Volume: |
12 |
Issue: |
4 |
Pages: |
313-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Charbonnier AS |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. |
Volume: |
190 |
Issue: |
12 |
Pages: |
1755-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sallusto F |
Year: |
1998 |
Journal: |
J Exp Med |
Title: |
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. |
Volume: |
187 |
Issue: |
6 |
Pages: |
875-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Strieter RM |
Year: |
1995 |
Journal: |
J Biol Chem |
Title: |
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. |
Volume: |
270 |
Issue: |
45 |
Pages: |
27348-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zlotnik A |
Year: |
2000 |
Journal: |
Immunity |
Title: |
Chemokines: a new classification system and their role in immunity. |
Volume: |
12 |
Issue: |
2 |
Pages: |
121-7 |
|
•
•
•
•
•
|